Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 881 results found. Search for [ US Food and Drug Administration ]

Results 1 to 21 of 881
BusinessToday.In
December 3, 2019
Ogivri will be launched at a competitive discount for customers to help ensure increased access to treatment for thousands of HER2-positive breast and gastric cancer patients, said Biocon


E Kumar Sharma
December 2, 2019
Earlier this month, AstraZeneca announced three large-scale initiatives to build on the company's long-standing commitment to China and advance global R&D for innovative new medicines


BusinessToday.In
November 29, 2019
Aurobindo Pharma share price gained 2.67% to Rs 462.2 compared to the previous close of Rs 450.20 on BSE


PTI
November 26, 2019
Glenmark's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications pending approval with the USFDA


E Kumar Sharma
New Delhi, November 25, 2019
Rajiv Malik, President, Mylan, speaks about the impact the deal will have on India operations, the challenges in generic drugs and the role that China will play


E Kumar Sharma
New Delhi, November 25, 2019
Self-medication and indiscriminate use of drugs to treat acidity and gas will cause more harm than good. their prolonged use may have serious consequences


BusinessToday.In
November 25, 2019
Snapping three-days losing streak, the share price of Unichem Laboratories opened higher, rising 7.4% to touch the day's high of Rs 164 apiece on the BSE


PTI
November 18, 2019
The significant violations included failure to have adequate written procedures for the receipt, identification, testing and handling of raw materials


PB Jayakumar
New Delhi, November 7, 2019
Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year


BusinessToday.In
New Delhi, November 6, 2019
Lupin Q2 results: Consolidated revenue from operations of the pharma major increased 10.3 per cent year-on-year (YoY) to Rs 4,359.7 crore in Q2FY20 as against Rs 3,951 crore in Q2FY19


PB Jayakumar
November 6, 2019
Most violations relate to rectifiable documentation, data maintenance, batch-wise consistent production quality, data on supply chain, stability issues, microbial contamination and quality checks


BusinessToday.In
November 5, 2019
After hitting intra day high of Rs 263.70, Biocon stock saw profit-booking and fell 3.11% to Rs 355 on BSE


BusinessToday.In
New Delhi, November 4, 2019
SPARC Q2 results: Total income declined sharply by 70.49 per cent to Rs 19.45 crore during the second quarter as compared with Rs 65.92 crore in the year-ago period


BusinessToday.In
November 4, 2019
The USFDA warning letter will not affect the existing business of Cadila Healthcare in the US and the existing product supplies from the Moraiya facility will continue


BusinessToday.In
November 4, 2019
HDFC Q2 results: The total revenue from operations increased by 10.35 per cent to Rs 10,478.33 crore in Q2FY20 from Rs 9,494.70 crore in Q2FY19


BusinessToday.In
November 4, 2019
Hikal share price gained up to 9.51% to Rs 131.90 compared to the previous close of Rs 120.45 on BSE


PB Jayakumar
New Delhi, October 30, 2019
Robots are changing the world of surgery, including in India


Reuters
Washington, October 25, 2019
Last week, J&J recalled around 33,000 bottles of baby powder in the United States after the health regulators found trace amounts of asbestos in samples taken from a bottle purchased online


PTI
New Delhi, October 13, 2019
Torrent Pharma recalls drugs from US, Puerto Rico: As per the report, Torrent Pharma Inc is recalling 17,088 bottles of Losartan Potassium /Hydrochlorothiazide tablets, USP 50mg/12.5mg from the same markets.


PTI
October 9, 2019



PAGES 1 OF 45  12345